An orally available, non-peptidic inhibitor of MMP-2, MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively) active in various animal models of tumor metastasis and has been used in a phase III clinical trial in pancreatic, SCLC, NSCLC, and
An orally available, non-peptidic inhibitor of MMP-2, MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively) active in various animal models of tumor metastasis and has been used in a phase III clinical trial in pancreatic, SCLC, NSCLC, and